AVUTOMETINIB

Clinical trials for AVUTOMETINIB explained in plain language.

Never miss a new study

Get alerted when new AVUTOMETINIB trials appear

Sign up with your email to follow new studies for AVUTOMETINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug cocktail targets Hard-to-Treat endometrial cancer

Disease control Not yet recruiting

This early-phase study tests a combination of three drugs (avutometinib, defactinib, and everolimus) in people with recurrent endometrial cancer that has specific genetic changes (RAS pathway mutations). The main goal is to find a safe dose and monitor side effects. About 31 part…

Matched conditions: AVUTOMETINIB

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 11, 2026 20:53 UTC

AVUTOMETINIB

Get alerted when new AVUTOMETINIB trials appear

New drug cocktail targets Hard-to-Treat endometrial cancer